Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | growth hormone secretagogue receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | rhodopsin-like orphan GPCR | growth hormone secretagogue receptor | 289 aa | 243 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0179 | 0.1922 | 0.8618 |
Schistosoma mansoni | N-myristoyltransferase | 0.0205 | 0.2231 | 1 |
Schistosoma mansoni | CREB-binding protein 2 | 0.0104 | 0.106 | 0.475 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0205 | 0.2231 | 0.5 |
Mycobacterium ulcerans | naphthoate synthase | 0.0874 | 1 | 0.5 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.0179 | 0.1922 | 0.8258 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0135 | 0.1413 | 0.6336 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0053 | 0.0461 | 0.2067 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.0053 | 0.0461 | 0.2067 |
Brugia malayi | TAZ zinc finger family protein | 0.0104 | 0.106 | 0.475 |
Echinococcus multilocularis | CREB binding protein | 0.0017 | 0.0046 | 0.0207 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.0179 | 0.1922 | 0.8618 |
Giardia lamblia | CDC72 | 0.0205 | 0.2231 | 0.5 |
Schistosoma mansoni | CREB-binding protein 1 (SmCBP1) | 0.0104 | 0.106 | 0.475 |
Loa Loa (eye worm) | choline O-acetyltransferase | 0.0193 | 0.2087 | 0.9355 |
Brugia malayi | Choline O-acetyltransferase | 0.0193 | 0.2087 | 0.9355 |
Onchocerca volvulus | 0.0053 | 0.0461 | 0.5 | |
Brugia malayi | Choline O-acetyltransferase | 0.0193 | 0.2087 | 0.9355 |
Echinococcus multilocularis | CREB binding protein | 0.0017 | 0.0046 | 0.0207 |
Schistosoma mansoni | choline o-acyltransferase | 0.0053 | 0.0461 | 0.2067 |
Mycobacterium tuberculosis | Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase) | 0.0874 | 1 | 0.5 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0205 | 0.2231 | 1 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0205 | 0.2231 | 1 |
Echinococcus granulosus | CREB binding protein | 0.0017 | 0.0046 | 0.0207 |
Onchocerca volvulus | 0.0053 | 0.0461 | 0.5 | |
Loa Loa (eye worm) | CBP-B | 0.0072 | 0.0689 | 0.309 |
Brugia malayi | N-myristoyltransferase 2 | 0.0205 | 0.2231 | 1 |
Echinococcus multilocularis | CREB binding protein | 0.0072 | 0.0679 | 0.3043 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0013 | 0 | 0.5 |
Echinococcus granulosus | CREB binding protein | 0.0104 | 0.106 | 0.475 |
Echinococcus multilocularis | CREB binding protein | 0.0017 | 0.0046 | 0.0207 |
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.0053 | 0.0461 | 0.2067 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0013 | 0 | 0.5 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0179 | 0.1922 | 0.8258 |
Schistosoma mansoni | choline o-acyltransferase | 0.0193 | 0.2087 | 0.9355 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0417 | 0.1867 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0205 | 0.2231 | 1 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0179 | 0.1922 | 0.8618 |
Leishmania major | N-myristoyl transferase, putative | 0.0205 | 0.2231 | 1 |
Trypanosoma brucei | N-myristoyltransferase | 0.0205 | 0.2231 | 1 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.0205 | 0.2231 | 1 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.0205 | 0.2231 | 1 |
Echinococcus multilocularis | choline O acetyltransferase | 0.0193 | 0.2087 | 0.9355 |
Echinococcus granulosus | choline O acetyltransferase | 0.0193 | 0.2087 | 0.9355 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.0205 | 0.2231 | 1 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0205 | 0.2231 | 1 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0205 | 0.2231 | 1 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.0053 | 0.0461 | 0.2067 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0205 | 0.2231 | 0.5 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0053 | 0.0461 | 0.2067 |
Echinococcus granulosus | CREB binding protein | 0.0064 | 0.0595 | 0.2668 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.0179 | 0.1922 | 0.8618 |
Loa Loa (eye worm) | carnitine O-palmitoyltransferase I isoform | 0.0053 | 0.0461 | 0.2067 |
Onchocerca volvulus | 0.0053 | 0.0461 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0193 | 0.2087 | 0.9355 |
Onchocerca volvulus | 0.0053 | 0.0461 | 0.5 | |
Echinococcus granulosus | CREB binding protein | 0.0017 | 0.0046 | 0.0207 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0179 | 0.1922 | 0.8258 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 0 % | Agonist activity at GHSR1a (unknown origin) expressed in CHO cells assessed as accumulation of intracellular calcium level at 10 uM relative to ghrelin | ChEMBL. | 18193826 |
Activity (functional) | = 0 % | Agonist activity at GHSR1a (unknown origin) expressed in CHO cells assessed as accumulation of intracellular calcium level at 10 uM relative to ghrelin | ChEMBL. | 18193826 |
IC50 (binding) | = 49 nM | Displacement of 125I-His9-ghrelin from human GHSR1a expressed in LLCPK1 cells | ChEMBL. | 18193826 |
IC50 (binding) | = 49 nM | Displacement of 125I-His9-ghrelin from human GHSR1a expressed in LLCPK1 cells | ChEMBL. | 18193826 |
Kb (functional) | = 129 nM | Antagonist activity at GHSR1a (unknown origin) expressed in CHO cells assessed as inhibition of ghrelin induced accumulation of intracellular calcium | ChEMBL. | 18193826 |
Kb (functional) | = 129 nM | Antagonist activity at GHSR1a (unknown origin) expressed in CHO cells assessed as inhibition of ghrelin induced accumulation of intracellular calcium | ChEMBL. | 18193826 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.